New thermometer put to the test in 373 people

NCT ID NCT06056011

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study checked how well a new thermometer, called TIMMY3, measures body temperature in people with fever. Researchers tested it on 373 people of all ages, from newborns to adults. The goal was to make sure the thermometer gives accurate readings compared to a standard medical thermometer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

373 people

The number who actually took part.

Started

Feb 2024

Finished

Mar 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 day to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Study subjects (person who is having their temperature taken) must meet the following criteria to participate in this study: * Subjects that are minors must provide assent to the clinical site's policy (if approved by Baxter) and/or the study sponsor's policy to participate in the study. * Subject or the legally authorized representative (LAR) must sign the informed consent form in order for the subject to participate. * Subject must be willing and able to comply with the study procedures. * Age: normal weight (full-term) newborn to adult * The study subject is in ambient temperature for at least 20 minutes prior to participating. * The study subject is able to have their temperature taken for up to six minutes for multiple rounds of temperatures per anatomical site. * The study subject is not physically or emotionally agitated/uncooperative. * The study subject or legal guardian speaks/understands fluent English. Exclusion Criteria: * Study subjects (person who is having their temperature taken) are excluded if they meet any of the below criteria. Any subject that withdraws from the study will be replaced. * The study subject has anatomical abnormalities that would affect temperature. * The study subject has any known contraindication to oral, axillary, or rectal temperature measurements. * The subject is not alert or unable to follow simple commands such as closing one's mouth completely around the probe if an oral reference temperature is being taken. * The study subject has consumed food or drink, or smoked, within the last 20 minutes. The subject may be included if they wait 20 minutes prior to taking oral temperature. * The study subject has engaged in strenuous or semi-strenuous activity within the last twenty minutes (i.e., running, weightlifting, etc.). * Subject has taken antipyretics (Aspirin, acetaminophen, ibuprofen) in the preceding 120 minutes. * Subjects has medical conditions such as inflammation at the MEASURING SITE (Barbiturates, thyroid preparations, antipsychotics, recent immunizations). * Neutropenic immunocompromised patients, in whom rectal manipulation may seed the blood with bacteria. Note: The study subject will be excluded if the reference temperature does not stabilize after the 3 -5 minute monitoring time.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Febrile illness are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • First Georgia Physicians Group

    Fayetteville, Georgia, 30214, United States

  • Forest Lane Pediatrics

    Dallas, Texas, 75230, United States

  • John R. Oishei Children's Hospital

    Buffalo, New York, 14203, United States

  • Mankato Clinic

    Mankato, Minnesota, 56001, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.